PRKDC and hepatocellular carcinoma: In hepatocellular carcinoma (HCC) cells, shRNA‐mediated inhibition of XRCC1 expression could increase DNA damage and cell cycle arrest, thereby making cancer cells more sensitive to γ‐rays; this might be due to decreases in DNA‐PKcs and gadd153 mRNA levels.28